These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8363369)

  • 1. Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist.
    Hughes WT; Jacobus DP; Canfield C; Killmar J
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1417-9. PubMed ID: 8363369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
    Brun-Pascaud M; Chau F; Garry L; Jacobus D; Derouin F; Girard PM
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2067-70. PubMed ID: 8878582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis.
    Hughes WT; Gray VL; Gutteridge WE; Latter VS; Pudney M
    Antimicrob Agents Chemother; 1990 Feb; 34(2):225-8. PubMed ID: 2327770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
    Canfield CJ; Milhous WK; Ager AL; Rossan RN; Sweeney TR; Lewis NJ; Jacobus DP
    Am J Trop Med Hyg; 1993 Jul; 49(1):121-6. PubMed ID: 8352384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
    Brun-Pascaud M; Chau F; Derouin F; Girard PM
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis.
    Hughes WT; McNabb PC; Makres TD; Feldman S
    Antimicrob Agents Chemother; 1974 Mar; 5(3):289-93. PubMed ID: 4365115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
    Hughes WT; Killmar JT; Oz HS
    J Infect Dis; 1994 Oct; 170(4):906-11. PubMed ID: 7930735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide.
    Hughes WT; Smith BL; Jacobus DP
    Antimicrob Agents Chemother; 1986 Mar; 29(3):509-10. PubMed ID: 3487287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia.
    Walzer PD; Foy J; Steele P; Kim CK; White M; Klein RS; Otter BA; Allegra C
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1935-42. PubMed ID: 1416884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
    Walzer PD; Foy J; Steele P; White M
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1436-43. PubMed ID: 8363372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis.
    Hughes WT; Smith BL
    Antimicrob Agents Chemother; 1984 Oct; 26(4):436-40. PubMed ID: 6335017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.
    Lasbury ME; Durant PJ; Bartlett MS; Smith JW; Lee CH
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):293-302. PubMed ID: 12626457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
    Hughes WT
    Antimicrob Agents Chemother; 1988 May; 32(5):623-5. PubMed ID: 3260765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole.
    Alder J; Mitten M; Shipkowitz N; Hernandez L; Hui YH; Marsh K; Clement J
    J Antimicrob Chemother; 1994 Feb; 33(2):253-63. PubMed ID: 8182006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employment of terbinafine against Pneumocystis carinii infection in rat models.
    Contini C; Colombo D; Cultrera R; Prini E; Sechi T; Angelici E; Canipari R
    Br J Dermatol; 1996 Jun; 134 Suppl 46():30-2; discussion 40. PubMed ID: 8763466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.
    Boylan CJ; Current WL
    Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM; Stokes DC; Yeh YY; Hughes WT
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
    Hughes WT; Killmar J
    Antimicrob Agents Chemother; 1996 Apr; 40(4):962-5. PubMed ID: 8849260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.
    Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C
    J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of trimetrexate, a potent lipid-soluble antifolate, in the treatment of rodent Pneumocystis carinii pneumonia.
    Kovacs JA; Allegra CJ; Kennedy S; Swan JC; Drake J; Parrillo JE; Chabner B; Masur H
    Am J Trop Med Hyg; 1988 Nov; 39(5):491-6. PubMed ID: 2973755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.